cross-protective monoclonal antibodies (TRIA Bioscience)

N/A

Report date: 2025/03/19 20:00:56

Base Information

Drug Namecross-protective monoclonal antibodies (TRIA Bioscience)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionImmunomodulators
TargetsUpdating
Therapy Area/IndicationsInfluenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTRIA Bioscience Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTRIA Bioscience Corp
Active IndicationsN/A
Inactive IndicationsInfluenza, Human

Other Information

ATC CodeN/A
Related LinksN/A